Startups
After working together for several years, IQuity and Decode Health combined operations in May 2022. The organization is now jointly known as Decode Health. Read more at www.decodehealth.ai/news.
IQuity is a research organization developing the next generation of blood-based, genomic tests to detect and monitor autoimmune disease.
IQuity continues to build an intellectual property portfolio focused on detecting and monitoring autoimmune disease. IQuity commercialized three genomic tests for multiple sclerosis, IBS versus Crohn’s and ulcerative colitis, and fibromyalgia syndrome. IQuity has transitioned from a commercial laboratory to a pure R&D organization that continues to receive NIH/SBIR grant funding.
IQuity is a research organization developing the next generation of blood-based, genomic tests to detect and monitor autoimmune disease.
IQuity continues to build an intellectual property portfolio focused on detecting and monitoring autoimmune disease. IQuity commercialized three genomic tests for multiple sclerosis, IBS versus Crohn’s and ulcerative colitis, and fibromyalgia syndrome. IQuity has transitioned from a commercial laboratory to a pure R&D organization that continues to receive NIH/SBIR grant funding.
Overview
Location
United States, Tennessee, Nashville
Employees
11-50
Total raised
$2.35M
Founded date
2013
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 17, 2017 | IQuity Raises $2.35m in Funding | IQuity, a Nashville, Tenn.-based life science tech company, raised $2.35m in funding. Backers were not disclosed. The company intends to use the funds to open its new CLIA-certified laboratory in Nashville. Led by Chase Spurlock, Founder an... |
| May 16, 2017 | A blood test for multiple sclerosis? Expect one in late May | To that end, Nashville, Tennesee-based IQuity will launch a first-of-its-kind blood test for MS in late May. The technology, originally licensed from Vanderbilt University, analyzes long non-coding RNA (lncRNA) in the patient’s blood to ide... |
| A blood test for multiple sclerosis? Expect one in late May | The medical toolbox for treating multiple sclerosis (MS) has progressed in leaps and bounds over the last two decades, as highlighted by the recent approval of Ocrevus for the most severe and treatment-resistant form of the disease. Despite... |
Reviews 0
FAQ about IQuity
When was IQuity founded?
IQuity was founded in 2013.
How much funding has IQuity raised?
IQuity has raised $2.35M in total across 1 funding round.
What has the press written about IQuity?
Parsers VC has collected 4 articles mentioning IQuity, among them “IQuity Raises $2.35m in Funding” (May 17, 2017) and “A blood test for multiple sclerosis? Expect one in late May” (May 16, 2017).
Is IQuity still active?
Yes, IQuity is active; its latest activity on Parsers VC dates from May 18, 2017.